U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07224087) titled 'Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients' on Oct. 23.
Brief Summary: The purpose of this research study is to develop and pilot a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery.
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Obesity
Smoking Cessation
Bariatric Surgery Patients
Intervention:
DRUG: Naltrexone Hydrochloride
Participants will be given 50mg/day of Naltrexone for 4 months.
DRUG: Bupropion HCl E...